Listen " Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West "
Episode Synopsis
Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West
In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements.
If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%.
MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe to the DeviceTalks Podcast Network.
More episodes of the podcast DeviceTalks Podcast Network
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs
14/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.